Bavar­i­an Nordic to test its Covid-19 boost­er against Pfiz­er/BioN­Tech shot in piv­otal study

As Bavar­i­an Nordic has made strides re­cent­ly to beef up its small­pox vac­cine man­u­fac­tur­ing in the wake of new mon­key­pox cas­es, the com­pa­ny is al­so get­ting ready to eval­u­ate its Covid-19 boost­er in a piv­otal study. And it’s go­ing af­ter one of the heavy­weights.

The Copen­hagen-based com­pa­ny an­nounced Thurs­day morn­ing it will be pit­ting its Covid-19 boost­er shot against Pfiz­er and BioN­Tech’s boost­er, re­design­ing its Phase III study to in­clude the com­para­tor. Bavar­i­an Nordic said the change will not im­pact its da­ta read­out time­line, ex­pect­ed be­fore the end of the year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER